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Introduction
Ethylene Oxide (EO) is a well know sterilizing agent. However, only recently has its use significantly emerged, based 
on its range of applications in the field of new medical device development and sterilisation. 
Advantages of this sterilization technology over other industrial sterilization technologies are addressed with the 
purpose of explaining why EO, despite many predictions about its demise as a sterilization alternative, is still a 
dominant mode of sterilization and continues to be used for increasing volumes of MDs.
An overview of the progress, in terms of EO sterilization optimisation is analysed  and issues, such as parametric 
release, lethality modelling and EO diffusion modelling, are discussed. Emphasis is given to a critical analysis about 
research topics requiring further attention.
One huge challenge is related with the development of mathematical models to integrate lethality in order to allow the 
definition of optimal microbiological inactivation conditions and, consequently, a continuous increase of process 
flexibility without compromising safety. The scientific community should also focus on other important issues, such as 
EO diffusion in different subtracts, taking into account different environmental conditions along both sterilization and 
aeration.
Objective
Provide an accurate reflection on ethylene oxide (EO) sterilization of medical devices (MDs) - a promising field to 
explore and develop.
EO STERILISATION
EO has allowed and contributed significantly to the advancement and revolution of delicate, complex and 
sophisticated MDs, that otherwise would not be viable due to the fact that for given sensitive materials EO is 
the only acceptable sterilisation method. 1 2, 3, 4, 5
Process Optimisation
§ Implementation of parametric release simply eliminates the microbiological test phase from routine;
§ Validation of aeration process allows assessment of EO residues in compliance with the requirements of 
ISO 10993-7;
§ Improvements in process design through lethality modelling / diffusion modellig;
Direct measurement of key process variables, as well as improvements in process design achieved through 
scientific modelling and experimental evidence, allows development of each process phase and consequent 
reduction in an overall sterilisation process time. 6
§ exceptional penetration properties of EO;
§ exceptional bactericidal, sporicidal and virucidal
properties of EO;
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EO diffusion modelling
The study of EO diffusion from the steriliser headspace to the articles, and through the articles, is a challenge matter
Objectives:
§ Definition of the specific relationship between EO concentration and process lethality ;
§ Efficiency comparison between different aeration methodologies;
§ Prediction of the dynamic distribution of EO concentration within the load;
Final Remark
Once the modelling of accumulated lethality, as well as the modelling of EO diffusion in
different matrices, is a perfectly apprehended matter, an overturn in the way of designing, 
validation and routine control of the EO sterilisation process will occur.
§ Patients, Staff, Environment;







§ Cost effectiveness; 
§ Flexibility;
§ How to short as possible overall sterilisation process time?
Lethality modelling
Mathematical models are essential for designing ethylene oxide sterilisation processes. 
Optimisation and validation of the different methodologies are a requirement. 5, 6, 7, 8
Definition of optimal microbiological inactivation conditions
The process gain in terms of efficiency and flexibility, and the industry movement towards parametric release, is much more 
scientifically supported.
< Cycle time and/or EO concentration reduction;
< Effectiveness and equivalency comparison of different 
sterilization processes;
Integrating EO Concentration and Temperature
Where, 
C EO concentration
F Equivalent process time; Exposure time at TR and CR that would cause the same lethal effect as 
the T(t) and C(t) temperature regimes
i Process step, for which the EO concentration and temperature are constant
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